Institutional investors control 2.59% of the outstanding shares in PURE. This represents a greater percentage of ownership than at almost any other company in the Medical Specialties industry. Additionally, during the quarter ended April 2015, these large investors purchased a net $60.5 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SENTINEL CAPITAL SOLUTIONS, INC. Bought 68.5 Thousand shares of PURE Biosciences Inc